Please use this identifier to cite or link to this item:
https://publication.npru.ac.th/jspui/handle/123456789/1609
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Racha, Satapat | - |
dc.contributor.author | Chaweekanlayakun, Wittaya | - |
dc.contributor.author | Suthep, Teerat | - |
dc.contributor.author | Sirisang, Khuantida | - |
dc.contributor.author | Racha, Kannika | - |
dc.date.accessioned | 2022-08-18T09:15:44Z | - |
dc.date.available | 2022-08-18T09:15:44Z | - |
dc.date.issued | 2022-07-08 | - |
dc.identifier.uri | https://publication.npru.ac.th/jspui/handle/123456789/1609 | - |
dc.description.abstract | Methionine Aminopeptidase 2 (MetAP2) is an enzyme that plays a vital role in regulating posttranslational processing and protein synthesis. MetAP2 is overexpressed in non-small cell lung cancer (NSCLC). Potential cytotoxicity of Jorunnamycin A-C from Jorunna funebris, has been reported, but the mechanism of action is unclear. The study aims to investigate the molecular interaction between Jorunnamycin A-C and MetAP2 by molecular modeling. The results showed that Jorunnamycin A is the most promising inhibitor of MetAP2. This finding provides a better understanding of the molecular basis for the cytotoxicity of Jorunna funebris. | en_US |
dc.publisher | The 14th NPRU National Academic Conference Nakhon Pathom Rajabhat University | en_US |
dc.subject | Lung cancer | en_US |
dc.subject | molecular modeling | en_US |
dc.subject | Methionine Aminopeptidase 2 | en_US |
dc.title | Identification of Small Molecule from Jorunna Funebris with Anti-lung Cancer Potential: Molecular Modeling Study | en_US |
dc.title.alternative | การตรวจพิสูจน์สารต้านมะเร็งปอดที่มีศักยะจากทากเปลือยโดยใช้แบบจำลองทางคอมพิวเตอร์ | en_US |
Appears in Collections: | Proceedings of the 14th NPRU National Academic Conference |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
npru-29.pdf | 307.14 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.